These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32334495)

  • 1. Review about Structure and Evaluation of Reactivators of Acetylcholinesterase Inhibited with Neurotoxic Organophosphorus Compounds.
    Figueroa-Villar JD; Petronilho EC; Kuca K; Franca TCC
    Curr Med Chem; 2021; 28(7):1422-1442. PubMed ID: 32334495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents.
    Mercey G; Verdelet T; Renou J; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
    Acc Chem Res; 2012 May; 45(5):756-66. PubMed ID: 22360473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of small organic molecule as reactivator of organophosphorus inhibited acetylcholinesterase.
    Thakur A; Patwa J; Pant S; Jeet Singh Flora S; Sharma A
    Drug Chem Toxicol; 2024 Jan; 47(1):26-41. PubMed ID: 36514993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
    Maxwell DM; Brecht KM; Sweeney RE
    Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro.
    Horn G; de Koning MC; van Grol M; Thiermann H; Worek F
    Toxicol Lett; 2018 Dec; 299():218-225. PubMed ID: 30312685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two possible orientations of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase.
    Luo C; Leader H; Radic Z; Maxwell DM; Taylor P; Doctor BP; Saxena A
    Biochem Pharmacol; 2003 Aug; 66(3):387-92. PubMed ID: 12907237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro investigation of efficacy of new reactivators on OPC inhibited rat brain acetylcholinesterase.
    Atanasov VN; Petrova I; Dishovsky C
    Chem Biol Interact; 2013 Mar; 203(1):139-43. PubMed ID: 23220589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties.
    Bhattacharjee AK; Kuca K; Musilek K; Gordon RK
    Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.
    Worek F; von der Wellen J; Musilek K; Kuca K; Thiermann H
    Arch Toxicol; 2012 Sep; 86(9):1379-86. PubMed ID: 22437842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between xylene-linked carbamoyl bis-pyridinium mono-oximes and organophosphates inhibited-AChE: a kinetic study.
    Sharma R; Gupta B; Acharya J; Kaushik MP; Ghosh KK
    Toxicology; 2014 Feb; 316():1-8. PubMed ID: 24345352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase.
    Winter M; Wille T; Musilek K; Kuca K; Thiermann H; Worek F
    Toxicol Lett; 2016 Feb; 244():136-142. PubMed ID: 26210933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximes.
    Worek F; Wille T; Koller M; Thiermann H
    Chem Biol Interact; 2013 Mar; 203(1):125-8. PubMed ID: 22827894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are the current commercially available oximes capable of reactivating acetylcholinesterase inhibited by the nerve agents of the A-series?
    Santos MC; Botelho FD; Gonçalves AS; Kitagawa DAS; Borges CVN; Carvalho-Silva T; Bernardo LB; Ferreira CN; Rodrigues RB; Ferreira Neto DC; Nepovimova E; Kuča K; LaPlante SR; Lima ALS; França TCC; Cavalcante SFA
    Arch Toxicol; 2022 Sep; 96(9):2559-2572. PubMed ID: 35666269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation kinetics of a series of related bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase--Structure-activity relationships.
    Worek F; Wille T; Koller M; Thiermann H
    Biochem Pharmacol; 2012 Jun; 83(12):1700-6. PubMed ID: 22649796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents.
    Renou J; Mercey G; Verdelet T; Păunescu E; Gillon E; Arboléas M; Loiodice M; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
    Chem Biol Interact; 2013 Mar; 203(1):81-4. PubMed ID: 23111374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study.
    Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R
    Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
    Scheffel C; Thiermann H; Worek F
    Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements of acetylcholinesterase reactivators.
    Kuca K; Juna D; Musilek K
    Mini Rev Med Chem; 2006 Mar; 6(3):269-77. PubMed ID: 16515465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds: pig versus minipig acetylcholinesterase.
    Worek F; Aurbek N; Wetherell J; Pearce P; Mann T; Thiermann H
    Toxicology; 2008 Feb; 244(1):35-41. PubMed ID: 18054823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies.
    Lo R; Ganguly B
    Mol Biosyst; 2014 Jul; 10(9):2368-83. PubMed ID: 24964273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.